SAVI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 2.663
EU - Europa 2.131
AS - Asia 1.252
AF - Africa 15
OC - Oceania 2
Totale 6.063
Nazione #
US - Stati Uniti d'America 2.599
CN - Cina 934
IE - Irlanda 460
UA - Ucraina 415
FI - Finlandia 379
SE - Svezia 360
DE - Germania 237
SG - Singapore 193
IT - Italia 189
TR - Turchia 99
CA - Canada 64
GB - Regno Unito 39
BE - Belgio 20
IN - India 14
NL - Olanda 13
CI - Costa d'Avorio 12
KR - Corea 7
AT - Austria 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IR - Iran 3
LT - Lituania 3
CH - Svizzera 2
FR - Francia 2
RO - Romania 2
AU - Australia 1
BG - Bulgaria 1
ES - Italia 1
HR - Croazia 1
IQ - Iraq 1
JP - Giappone 1
LU - Lussemburgo 1
NZ - Nuova Zelanda 1
Totale 6.063
Città #
Jacksonville 539
Dublin 459
Chandler 361
Dearborn 264
Beijing 237
Boardman 150
Ashburn 146
Singapore 145
Nanjing 136
Princeton 109
San Mateo 100
Izmir 97
Ann Arbor 72
Toronto 63
Shenyang 53
Helsinki 51
Wilmington 50
Nanchang 49
New York 42
Kunming 41
Hefei 40
Hebei 38
Jinan 33
Los Angeles 33
Des Moines 27
Jiaxing 26
Shanghai 23
Changsha 20
Tianjin 18
Brussels 15
Santa Clara 15
Haikou 13
Rome 13
Abidjan 12
Norwalk 12
Guangzhou 11
Woodbridge 11
Ningbo 10
Seattle 10
Fremont 9
Fuzhou 9
Monmouth Junction 9
Florence 8
Taizhou 8
Zhengzhou 8
Milan 7
Naples 7
Rockville 7
Augusta 6
Chengdu 6
Leawood 6
Chongqing 5
Hangzhou 5
Seongnam 5
Taiyuan 5
Waanrode 5
Wuhan 5
Baotou 4
Borås 4
Faenza 4
Houston 4
Auburn Hills 3
Aversa 3
Birmingham 3
Bremen 3
Brno 3
Dallas 3
Mumbai 3
Palermo 3
Parma 3
Rio Saliceto 3
Shaoxing 3
Tappahannock 3
Trieste 3
Vienna 3
Ardabil 2
Bacoli 2
Bologna 2
Bonate Sotto 2
Cairo 2
Düsseldorf 2
Ferrara 2
Focsani 2
Grafing 2
Kocaeli 2
Lugano 2
Mestre 2
Munich 2
Nanning 2
Napoli 2
Pavia 2
Perugia 2
Ponte A Moriano 2
Seoul 2
Wenzhou 2
Xian 2
Acireale 1
Al Mansurah 1
Alghero 1
Amsterdam 1
Totale 3.768
Nome #
Oligonucleotide Ligation Assay (OLA) e mutazioni silenti del gene CFTR: una rara causa di parziale fallimento del test 136
TRAPIANTO COMBINATO FEGATO-RENE CON CROSS-MATCH POSITIVO:CONTROINDICAZIONE O OPPORTUNITÀ? 89
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: mRNA levels, protein expression and urinary loss 84
Alterations of type IV collagen alpha chains in patients with chronic acquired glomerulopathies: analogies with Alport’s syndrome 83
Fluorescent in situ hybridisation on tissue sections: a quantitative approach with confocal laser scanning microscopy 81
BRCA mutations, molecular markers, and clinical variables in early-onset breast cancer: A population-based study. 80
Ruolo dei geni del collagene di tipo IV e dei loro prodotti proteici nelle glomerulopatie umane acquisite 78
BRCA-1 status, molecular markers and clinical viariables in breast cancer (BC) patients with high probability of having an inherited cancer predisposing genetic mutation 77
Valutazione del gene COL4A5 e del suo prodotto proteico nelle nefropatie glomerulari acquisite 77
Insulin dependent diabetes mellitus (IDDM): 12th International Histocompatibility Workshop study 77
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 76
Tipizzazione dei polimorfismi dei geni del locus HLA, delle citochine e dei loro recettori nella Fibrosi Retroperitoneale Idiopatica (FRI) 72
Correlazione fra HLA-DRB1*03 e periaortite cronica: una ipotesi di origine autoimmune 70
Molecular profile and clinical variables in BRCA1-positive breast cancers. A population-based study 69
A breast cancer patient from Italy with germline mutations in both the BRCA1 and BRCA2 genes 69
BRCA1 and BRCA2 status in a sample of italian women with early onset breast cancer (EOBC) 68
Chronic periaortitis and HLA–DRB1*03: Another clue to an autoimmune origin 68
Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin 67
Febbre Mediterranea Familiare e Sindrome Associata a mutazioni nel recettore TNF-alfa: nuove varianti ed interazioni fra i due geni 66
Appearance and evolution of anti-Da (B cell-specific) antibodies after planned immunizations. 66
Human T-cell receptor alpha chain gene during ontogeny 65
T-cell receptor beta-chain gene rearrangement and expression during human thymic ontogenesis. 65
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 65
Alport syndrome in Italy. A multicenter screening for COL4A5 gene mutations 65
Immunological abnormalities in a family with progressive external ophtalmoplegia 65
CDC – XM NEGATIVO E RIGETTO IPERACUTO 64
Riconoscimento in situ di RNA messaggeri umani specifici mediante microscopia confocale in fluorescenza 64
Clinical heterogeneity of hereditary coproporphyria: diagnostic usefulness of biochemical studies. Study of a familial case 64
DUPLICAZIONE DELL DELL’ESONE 13 DEL GENE F8 NEI P ’ESONE PAZIENTI EMOFILICI CON AZIENTI FENO FENOTIPO LIEVE: TIPO LA CASISTICA DELLA REGIONE EMILIA ROMA ROMAGNA GNA 64
BRCA1 status. Molecular markers and clinical variables in breast cancer (BC) patients with high probability of having an inherited, cancer-predisposing genetic mutation 63
Clinical, histopathological and biochemical findings in Fabry's disease. A case report 62
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 62
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 61
Malattia di Fabry e linfedema familiare. Descrizione di due casi 61
Mesangio-proliferative glomerulonephritis with prevalent deposits of IgA and histocompatibility antigens 61
Ruolo dei geni del collageno di tipo 4 nelle glomerulopatie acquisite 61
X-linked Alport syndrome: an SSCP-based mutation survey over all 51 exons of the COL4A5 gene. 61
Genetica della Febbre Mediterranea Familiare in Italia 60
Fabry's Disease with Familial Lymphedema of the Lower Limbs. Case Report and Family Study 60
La tecnica multiplex ligation probe amplification (MLPA) per la determinazione dello stato di portatrice in emofilia. 59
Role of the 4A5 collagen gene and its product in human acquired glomerulopathies 59
HLA ANTIGENS AND INSULIN DEPENDENT DIABETES MELLITUS. A FAMILY STUDY 59
Expression of TCR beta chain gene N-diversity is not an early event in human thymic ontogeny 59
Lymphocyte antibody lymphocytolytic interaction (LALI) with special enphasis on HLA 59
Ulteriori nuove mutazioni sul gene COL4A5 mediante PCR e sequenziamento diretto 59
Febbre Mediterranea Familiare (FMF) e sindrome associata a mutazioni del recettore del TNF-alfa (TRAPS): nuove varianti e cross-talk fra i 2 geni. 59
Rapid and sensitive MLPA approach for identification of deletion carriers in haemophilia 58
HLA-DRB1 e TNF, ma non CFTR, sono fattori di rischio per la colangite sclerosante 58
HLA-DR antigens and cardiolipin antibodies in northen Italian systemic erythematosus patients. 57
RECIPROCHE IMPLICAZIONI DEL TRAPIANTO DI TESSUTI E DI ORGANI SOLIDI 57
Different expression of BRCA1 status and clinical variables in a sample of Italian women with early onset breast cancer (EOBC) 56
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 55
Toxicity due to remission inducing drugs in rheumatoid arthritis. Association with HLA-B35 and Cw4 antigens. 55
L'ANALISI MUTAZIONALE DEL GENE COL4A5 MEDIANTE SEQUENZIAMENTO DIRETTO RENDE POSSIBILE LA DIAGNOSI NELLA QUASI TOTALITA'DEI CASI 55
Sospetta eterogeneità genetica nella Febbre Mediterranea Familiare 54
Association between DR antigens, rheumatoid arthritis with and without features and systemic lupus erythematousus in northern Italy. 54
Male breast cancer (MBC) in Parma province: descriptive epidemiology, molecular markers and clinical variables. 54
Production of anti HLA antisera by planned immunisations 54
Missense mutations in the COL4A5 gene in patients with X-linked Alport syndrome 54
Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations. 53
Anti HLA antibody evolution in recipients of planned transfusions 53
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation 53
CORRELAZIONE FRA HLA-DRB1*03 E PERIAORTITE CRONICA: UNA IPOTESI DI ORIGINE AUTOIMMUNE 52
HLA antigens and IgA mesangial glomerulonephritis 52
HLA-DR antigens and anticardiolipin antibodies in northern Italian systemic lupus erythematosus patients. 51
Medicina genomica. Prospettive e limiti 50
What strategy for improving HLA alloimmunization screening in cadaver kidney transplant waiting list? A regional experience (Emilia Romagna-Italy). 50
HLA and type 1 diabetes: a prospective study of all new cases diagnosed in Piedmont one year 50
T-cell receptor beta chain gene rearrangement and expression during human thymic ontogenesis. 50
Screening del gene COL4A5 mediante sequenziamento diretto in pazienti affetti da Sindrome di Alport 50
Missense mutations in the COL4A5 gene in patients with X-linked Alport Syndrome. 49
The role of HLA polymorphism in susceptibility to Churg-Strauss syndrome and their influence on disease phenotype 49
HLA-DR frequecies in northen Italy 48
Hypergammaglobulinemic purpura of Waldenström. (A report of serologic and immunogenetic studies and long-term follow-up in 18 patients). 48
Terminal deoxynucleotidyl transferase (TDT) expression correlates with the presence of N regions during human thymic ontogeny 48
Screeniong for B cell specific antisera. Results from region Italy 1 48
Ruolo dei polimorfismi dei geni dei fattori della coagulazione nella glomerulosclerosi focale e segmentaria idiopatica 47
The presence of posttransplant HLA-specific IgG antibodies detected by immunosorbent assay correlates with specific rejection pathologies. 47
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 47
Patient waiting for kidney transplantation with antibodiea vs previous bone allograft. A case report 46
REPORT OF THE ITALIAN MULTICENTER STUDY ON ALPORT SYNDROME 46
Serologic and genetic aspects of HLA DR antigen study 46
Spettro di mutazioni nel gene F8 in pazienti affetti da Emofilia A della Regione Emilia Romagna. 45
TCR beta chian gene ontogeny in human thymus 45
Patient waiting for kidney transplantation with antibodies vs previous bone allograft. A case report 44
Preliminary results of donor specific antibody (DSA) determination by Luminex vs CDC-XM in living and cadaveric kidney transplantation: a regional experience 44
POlimorfisni dei geni delle citochine e dei loro recettori nella Sindrome di Churg-Strauss 43
Similarity of the genetic background in rheumatic diseases between northen patients. 43
Il paziente con anticorpi anti HLA 43
Major COL4A5 gene rearrangements in patients with juvenile type Alport syndrome. 42
Studio in CDC dei sieri dei pazienti in lista di attesa per trapianto renale. E' ancora attuale nell'epoca della citofluorimetria? 42
IS HIGH RESOLUTION TYPING IN KIDNEYTRANSPLANTATION WORTHWHILE? A CASE REPORT INTHE LUMINEX ERA 42
POSITIVE CROSS-MATCH (XM) BEFORE A COMBINED KIDNEY-LIVER TRANSPLANTATION. A CASE REPORT 40
PRELIMINARY RESULTS OF DONOR SPECIFIC ANTIBODY(DSA) DETERMINATION BY LUMINEX VS CDC-XM INLIVING AND CADAVERIC KIDNEY TRANSPLANTATION: AREGIONAL EXPERIENCE 40
Some immunological reactions during chronic treatment with antiepilectic drugs 40
Mutation scanning of the entire COL4A5 coding sequence in Alport syndrome and genotype-phenotype correlation. 39
Secondary and Primary Vasculitis Study Group.HLA-DRB4 as a genetic risk factor for Churg-Strauss syndrome: 39
TCR-beta chain gene rearrangement and expression in human T-cell development and leukemia. 38
Febbre Mediterranea Familiare : necessità di accesso al test genetico sulla base del parere di un clinico esperto. 38
DUPLICAZIONE DELL DELL’ESONE 13 DEL GENE F8 NEI P ’ESONE PAZIENTI EMOFILICI CON AZIENTI FENO FENOTIPO LIEVE: TIPO LA CASISTICA DELLA REGIONE EMILIA ROMA ROMAGNA GNA 38
Totale 5.758
Categoria #
all - tutte 21.003
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.003


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020987 0 0 0 23 155 180 209 25 120 115 43 117
2020/2021757 9 113 64 5 113 3 73 5 208 6 156 2
2021/2022472 3 3 9 16 12 4 73 98 22 29 46 157
2022/20231.547 199 145 103 102 117 177 10 80 555 2 48 9
2023/2024478 19 70 15 7 44 140 14 30 7 19 45 68
2024/2025403 109 120 129 45 0 0 0 0 0 0 0 0
Totale 6.069